BEAT News and Press, Heartbeam Inc. From 12/21/20

M&A momentum continued to build with seven new deals announced. Lockheed Martin Corporation (LMT) announced that it is acquiring Aerojet Rocketdyne Holdings (AJRD). The acquisition of TC PipeLines (TCP) by TC Energy Corporation (TRP). For further details see: Merger ...

CNS Pharmaceuticals (CNSP) +62%.Cyclo Therapeutics (CYTH) +47%.Mereo BioPharma Group (MREO) +38% on licensing pact with Ultragenyx.DermTech (DMTK) +23% after announcing topline results from its TRUST Study of the company’s non-invasive melanoma rule-out test, the Pigmented Le...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Tesla makes grand entrance into S&P 500Index funds tracking the S&P 500 have a small window today to buy nearly $80B worth of Tesla (TSLA) stock as...

Philips (PHG) has agreed to buy U.S. cardiac diagnostics and monitoring firm BioTelemetry (BEAT) $2.8B, sending shares of the latter up 15% in premarket trade. Philips will pay $72 per outstanding BioTelemetry share in cash, marking a 16.5% premium to the stock's closing price on Thursday.Bio...

Philips to acquire BioTelemetry, Inc. for USD 72.00 per share; implied enterprise value of USD 2.8 billion (approx. EUR 2.3 billion) Acquisition is a strong fit with Philips’ strategy to transform the delivery of healthcare: combination of Philips’ leading patient ...

BioTelemetry has had a better than expected third quarter, leveraging new patient uptake plus clinician accounts in their healthcare and continuous care segments. Management have secured better lending terms on their revolving facility, and cash runaway is well over 2 years. We se...

Image source: The Motley Fool. BioTelemetry Inc (NASDAQ: BEAT) Q3 2020 Earnings Call Oct 29, 2020 , 5:00 p.m. ET Operator Continue reading For further details see: BioTelemetry Inc (BEAT) Q3 2020 Earnings Call Transcript

BioTelemetry, Inc. (BEAT) Q3 2020 Earnings Conference Call October 29, 2020 5:00 PM ET Company Participants Joseph Capper – President and Chief Executive Officer Heather Getz – Chief Financial Officer Conference Call Participants David Saxon – Needham Jayson Bedford ...

BioTelemetry (BEAT): Q3 Non-GAAP EPS of $0.45 beats by $0.07; GAAP EPS of $0.18 beats by $0.01.Revenue of $114.66M (+3.0% Y/Y) beats by $9.54M.Adj. EBITDA margin of 26.7% vs 28.3% Y/Y.Shares +0.94%.Press Release For further details see: BioTelemetry EPS beats by $0.07, beats on revenue ...

MALVERN, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended September 30, 2...